{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T21:06:52Z","timestamp":1776805612763,"version":"3.51.2"},"reference-count":276,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neurobiology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.pneurobio.2012.08.004","type":"journal-article","created":{"date-parts":[[2012,8,28]],"date-time":"2012-08-28T15:31:17Z","timestamp":1346167877000},"page":"262-280","source":"Crossref","is-referenced-by-count":22,"title":["Therapeutic approaches to preventing cell death in Huntington disease"],"prefix":"10.1016","volume":"99","author":[{"given":"Anna","family":"Kaplan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brent R.","family":"Stockwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pneurobio.2012.08.004_bib0005","unstructured":"Accera, Inc., 2012. Product Pipeline. Retrieved February 5, 2012 from www.accerapharma.com\/products.html."},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0010","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.nurt.2008.01.008","article-title":"Symptomatic treatment of Huntington disease","volume":"5","author":"Adam","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuron.2008.06.018","article-title":"Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta","volume":"59","author":"Adlard","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0020","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0361-9230(01)00775-4","article-title":"Neuroprotection by neurotrophins and GDNF family members in the excitotoxic model of Huntington's disease","volume":"57","author":"Alberch","year":"2002","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0025","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.nbd.2004.04.001","article-title":"A cell-based screen for drugs to treat Huntington's disease","volume":"16","author":"Aiken","year":"2004","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0030","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2174\/156802607782341082","article-title":"Fragment-based drug discovery: what has it achieved so far?","volume":"7","author":"Alex","year":"2007","journal-title":"Current Topics in Medicinal Chemistry"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0035","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1016\/j.bmcl.2003.08.024","article-title":"Identification of potent and novel small-molecule inhibitors of caspase-3","volume":"13","author":"Allen","year":"2003","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0040","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0092-8674(00)81334-3","article-title":"Human ICE\/CED-3 protease nomenclature","volume":"87","author":"Alnemri","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0045","unstructured":"Alnylam Pharmaceuticals, Inc., 2011. News Release: Alnylam Launches \u201cAlnylam 5\u00d715\u201d Product Strategy and Provides Guidance and Goals for 2011. Retrieved May 3, 2011 from http:\/\/phx.corporate-ir.net\/phoenix.zhtml?c=148005&p=irol-newsArticle&ID=1513530&highlight=."},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0050","unstructured":"Alzheimer's Association, 2010. Changing the Trajectory of Alzheimer's Disease: A National Imperative. Retrieved April 20, 2011 from www.alz.org\/trajectory."},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF02257483","article-title":"Structure and expression of the Huntington's disease gene: evidence against simple inactivation due to an expanded CAG repeat","volume":"20","author":"Ambrose","year":"1994","journal-title":"Somatic Cell and Molecular Genetics"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0060","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/ng1095-115","article-title":"HEAT repeats in the Huntington's disease protein","volume":"11","author":"Andrade","year":"1995","journal-title":"Nature Genetics"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0065","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1212\/01.wnl.0000334276.09729.0e","article-title":"Weight loss in Huntington disease increases with higher CAG repeat number","volume":"71","author":"Aziz","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0070","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/S0140-6736(03)13304-1","article-title":"Huntingtin aggregation and toxicity in Huntington's disease","volume":"361","author":"Bates","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0075","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/brain\/awf180","article-title":"Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation","volume":"125","author":"Behrens","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0080","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1212\/WNL.0b013e31821b7cc9","article-title":"NMDA receptors: recent insights and clinical correlations","volume":"76","author":"Benarroch","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0085","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1091\/mbc.E05-07-0607","article-title":"Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin","volume":"17","author":"Benchoua","year":"2006","journal-title":"Molecular Biology of the Cell"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/0888439002250448","article-title":"Effectiveness of physiotherapy, occupational therapy, and speech pathology for people with Huntington's disease: a systematic review","volume":"17","author":"Bilney","year":"2003","journal-title":"Neurorehabilitation & Neural Repair."},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0095","doi-asserted-by":"crossref","first-page":"8732","DOI":"10.1021\/ja902302h","article-title":"970 million druglike small molecules for virtual screening in the chemical universe database GDB-13","volume":"131","author":"Blum","year":"2009","journal-title":"Journal of American Chemical Society"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0100","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0092-8674(00)81265-9","article-title":"Involvement of MACH, a novel MORT1\/FADD-interacting protease, in Fas\/APO-1- and TNF receptor-induced cell death","volume":"85","author":"Boldin","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0105","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/nature09454","article-title":"Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma","volume":"467","author":"Bollag","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0110","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.2174\/138161206777698693","article-title":"Pharmacological management of Huntington's disease: an evidence-based review","volume":"12","author":"Bonelli","year":"2006","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0115","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1172\/JCI27607","article-title":"Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase","volume":"116","author":"Borrell-Pages","year":"2006","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0120","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nsmb1043","article-title":"Structural definition of the F-actin-binding THATCH domain from HIP1R","volume":"13","author":"Brett","year":"2006","journal-title":"Nature Structural & Molecular Biology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0125","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1073\/pnas.92.15.7105","article-title":"Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates","volume":"92","author":"Brouillet","year":"1995","journal-title":"Proceedings of the National Academy of Sciences United States of America"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0130","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.410410514","article-title":"Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia","volume":"41","author":"Browne","year":"1997","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0135","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cub.2011.04.028","article-title":"The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease","volume":"21","author":"Campesan","year":"2011","journal-title":"Current Biology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0140","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S1359-6446(05)03511-7","article-title":"Fragment-based lead discovery: leads by design","volume":"10","author":"Carr","year":"2005","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0145","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/mt.2011.201","article-title":"Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene\/allele-specific silencing of mutant huntingtin","volume":"19","author":"Carroll","year":"2011","journal-title":"Molecular Therapy"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0150","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/80538","article-title":"Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease","volume":"6","author":"Chen","year":"2000","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0155","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.nbd.2005.11.001","article-title":"Decreased association of the transcription factor Sp1 with genes downregulated in Huntington's disease","volume":"22","author":"Chen-Plotkin","year":"2006","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0160","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.1016\/j.febslet.2006.08.076","article-title":"Huntingtin-interacting protein 1-mediated neuronal cell death occurs through intrinsic apoptotic pathways and mitochondrial alterations","volume":"580","author":"Choi","year":"2006","journal-title":"FEBS Letters"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0165","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/hmg\/ddh162","article-title":"Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release","volume":"13","author":"Choo","year":"2004","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0170","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1021\/jm020230j","article-title":"Identification of potent and selective small-molecule inhibitors of caspase-3 through the use of extended tethering and structure-based drug design","volume":"45","author":"Choong","year":"2002","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0175","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1021\/jm900135r","article-title":"Synthesis and in vitro evaluation of sulfonamide isatin Michael acceptors as small molecule inhibitors of caspase-6","volume":"52","author":"Chu","year":"2009","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0180","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/20367","article-title":"Structure of importin-beta bound to the IBB domain of importin-alpha","volume":"399","author":"Cingolani","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0185","unstructured":"ClinicalTrials.gov, 2012. CIT-HD. Study in Huntington's Disease. Retrieved February 15, 2012 from http:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT00271596?cond=Huntington&intr=citalopram&rank=1."},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0190","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/467283a","article-title":"Cell biology: a sensor for calcium uptake","volume":"467","author":"Collins","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0195","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1021\/jm061197u","article-title":"Application of fragment screening by X-ray crystallography to the discovery of aminopyridines as inhibitors of beta-secretase","volume":"50","author":"Congreve","year":"2007","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0200","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1146\/annurev-biochem-061809-121639","article-title":"Caspase substrates and cellular remodeling","volume":"80","author":"Crawford","year":"2011","journal-title":"Annual Review of Biochemistry"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0205","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1471-4159.2011.07402.x","article-title":"The Alzheimer's therapeutic PBT2 promotes amyloid-beta degradation and GSK3 phosphorylation via a metal chaperone activity","volume":"119","author":"Crouch","year":"2011","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0210","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1126\/science.273.5274.501","article-title":"A receptor for the selective uptake and degradation of proteins by lysosomes","volume":"273","author":"Cuervo","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0215","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0220","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jmb.2007.09.023","article-title":"Flanking polyproline sequences inhibit beta-sheet structure in polyglutamine segments by inducing PPII-like helix structure","volume":"374","author":"Darnell","year":"2007","journal-title":"Journal of Molecular Biology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0225","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1136\/jmg.30.12.996","article-title":"Dynamic mutation in Dutch Huntington's disease patients: increased paternal repeat instability extending to within the normal size range","volume":"30","author":"De Rooij","year":"1993","journal-title":"Journal of Medical Genetics"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0230","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S1474-4422(11)70233-2","article-title":"Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial","volume":"10","author":"de Yebenes","year":"2011","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0235","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1046\/j.1471-4159.2003.01706.x","article-title":"Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice","volume":"85","author":"Dedeoglu","year":"2003","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0240","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nchembio711","article-title":"Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury","volume":"1","author":"Degterev","year":"2005","journal-title":"Nature Chemical Biology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0245","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0968-0004(90)90019-8","article-title":"Peptide sequences that target cytosolic proteins for lysosomal proteolysis","volume":"15","author":"Dice","year":"1990","journal-title":"Trends in Biochemical Sciences"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0250","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0255","doi-asserted-by":"crossref","first-page":"17204","DOI":"10.1073\/pnas.0708285104","article-title":"Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits","volume":"104","author":"DiFiglia","year":"2007","journal-title":"Proceedings of the National Academy of Sciences United States of America"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0260","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of non-apoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0265","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1212\/01.WNL.0000031791.10922.CF","article-title":"Weight loss in early stage of Huntington's disease","volume":"59","author":"Djousse","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0270","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1126\/science.1072613","article-title":"Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease","volume":"296","author":"Dunah","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0275","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.7618107","article-title":"Inactivation of the mouse Huntington's disease gene homolog Hdh","volume":"269","author":"Duyao","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0280","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1146\/annurev.biochem.68.1.383","article-title":"Mammalian caspases: structure, activation, substrates, and functions during apoptosis","volume":"68","author":"Earnshaw","year":"1999","journal-title":"Annual Review of Biochemistry"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0285","unstructured":"Edison Pharmaceuticals Inc, 2011. Technology. Retrieved April 20, 2011 from edisonpharma.com\/RnD.aspx."},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0290","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1021\/jm070829p","article-title":"Application of fragment-based lead generation to the discovery of novel, cyclic amidine beta-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency","volume":"50","author":"Edwards","year":"2007","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0295","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1093\/hmg\/ddl210","article-title":"Green tea (\u2212)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models","volume":"15","author":"Ehrnhoefer","year":"2006","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0300","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/sj.embor.7400311","article-title":"The human protein disulphide isomerase family: substrate interactions and functional properties","volume":"6","author":"Ellgaard","year":"2005","journal-title":"EMBO Reports"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0305","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ymgme.2011.10.009","article-title":"Initial experience in the treatment of inherited mitochondrial disease with EPI-743","volume":"105","author":"Enns","year":"2012","journal-title":"Molecular Genetics and Metabolism"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0310","doi-asserted-by":"crossref","first-page":"9367","DOI":"10.1073\/pnas.97.17.9367","article-title":"Site-directed ligand discovery","volume":"97","author":"Erlanson","year":"2000","journal-title":"Proceedings of the National Academy of Sciences United States of America"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0315","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.copbio.2006.10.007","article-title":"Fragment-based lead discovery: a chemical update","volume":"17","author":"Erlanson","year":"2006","journal-title":"Current Opinion in Biotechnology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/128_2011_180","article-title":"Introduction to fragment-based drug discovery","volume":"317","author":"Erlanson","year":"2012","journal-title":"Topics in Current Chemistry"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0325","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.nbd.2008.12.017","article-title":"Glutamate toxicity in the striatum of the R6\/2 Huntington's disease transgenic mice is age-dependent and correlates with decreased levels of glutamate transporters","volume":"34","author":"Estrada-Sanchez","year":"2009","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0330","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1523\/JNEUROSCI.20-12-04389.2000","article-title":"Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease","volume":"20","author":"Ferrante","year":"2000","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0335","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1124\/mi.9.1.7","article-title":"Fragment-based ligand discovery","volume":"9","author":"Fischer","year":"2009","journal-title":"Molecular Interventions"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0340","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1126\/science.291.5506.1051","article-title":"Simultaneous binding of PtdIns(4,5)P2 and clathrin by AP180 in the nucleation of clathrin lattices on membranes","volume":"291","author":"Ford","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0345","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nature01020","article-title":"Curvature of clathrin-coated pits driven by epsin","volume":"419","author":"Ford","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0350","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/jnnp.66.1.52","article-title":"Differences in duration of Huntington's disease based on age at onset","volume":"66","author":"Foroud","year":"1999","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry."},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0355","doi-asserted-by":"crossref","first-page":"10166","DOI":"10.1021\/bi101208k","article-title":"Allele-selective inhibition of mutant huntingtin expression with antisense oligonucleotides targeting the expanded CAG repeat","volume":"49","author":"Gagnon","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0360","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1471-4159.2005.03341.x","article-title":"Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion","volume":"95","author":"Gal","year":"2005","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0365","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/cdd.2011.96","article-title":"Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012","volume":"19","author":"Galluzzi","year":"2012","journal-title":"Cell Death & Differentiation"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0370","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","article-title":"Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules","volume":"118","author":"Gauthier","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0375","unstructured":"Genervon Biopharmaceuticals, LLC, 2012. Pipeline. Retrieved February 5, 2012 from www.genervon.com\/genervon\/medicines_pipeline.php."},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0380","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ncb735","article-title":"Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi","volume":"4","author":"Gervais","year":"2002","journal-title":"Nature Cell Biology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0385","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.1021\/jm070825k","article-title":"Discovery of a novel warhead against beta-secretase through fragment-based lead generation","volume":"50","author":"Geschwindner","year":"2007","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0390","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.pnpbp.2010.11.023","article-title":"Potential of cystamine and cysteamine in the treatment of neurodegenerative diseases","volume":"35","author":"Gibrat","year":"2011","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0395","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1128\/MCB.25.4.1354-1366.2005","article-title":"Control of mitochondrial transcription specificity factors (TFB1M and TFB2M) by nuclear respiratory factors (NRF-1 and NRF-2) and PGC-1 family coactivators","volume":"25","author":"Gleyzer","year":"2005","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0400","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.phrs.2005.01.006","article-title":"Prevention of cytosolic IAPs degradation: a potential pharmacological target in Huntington's Disease","volume":"52","author":"Goffredo","year":"2005","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0405","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1136\/jmg.30.12.987","article-title":"Familial predisposition to recurrent mutations causing Huntington's disease: genetic risk to sibs of sporadic cases","volume":"30","author":"Goldberg","year":"1993","journal-title":"Journal of Medical Genetics"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0410","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/ng0896-442","article-title":"Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract","volume":"13","author":"Goldberg","year":"1996","journal-title":"Nature Genetics"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0415","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","article-title":"Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin","volume":"125","author":"Graham","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0420","doi-asserted-by":"crossref","first-page":"15019","DOI":"10.1523\/JNEUROSCI.2071-10.2010","article-title":"Cleavage at the 586 amino acid caspase-6 site in mutant huntingtin influences caspase-6 activation in vivo","volume":"30","author":"Graham","year":"2010","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0425","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1755-5949.2010.00184.x","article-title":"Targeting histone deacetylases for the treatment of Huntington's disease","volume":"16","author":"Gray","year":"2010","journal-title":"CNS Neuroscience & Therapeutics"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0430","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0092-8674(00)80963-0","article-title":"The structure of the protein phosphatase 2A PR65\/A subunit reveals the conformation of its 15 tandemly repeated HEAT motifs","volume":"96","author":"Groves","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0435","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.410390317","article-title":"Mitochondrial defect in Huntington's disease caudate nucleus","volume":"39","author":"Gu","year":"1996","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0440","doi-asserted-by":"crossref","first-page":"41299","DOI":"10.1074\/jbc.M008408200","article-title":"Huntingtin interacting protein 1 induces apoptosis via a novel caspase-dependent death effector domain","volume":"275","author":"Hackam","year":"2000","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0445","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrd2220","article-title":"A decade of fragment-based drug design: strategic advances and lessons learned","volume":"6","author":"Hajduk","year":"2007","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0450","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1021\/ci000403i","article-title":"Molecular complexity and its impact on the probability of finding leads for drug discovery","volume":"41","author":"Hann","year":"2001","journal-title":"Journal of Chemical Information and Computer Science"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0455","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nature04724","article-title":"Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice","volume":"441","author":"Hara","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0460","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1146\/annurev.pharmtox.47.120505.105311","article-title":"Cell signaling and neuronal death","volume":"47","author":"Hara","year":"2007","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0465","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF00194305","article-title":"The epidemiology of Huntington's disease","volume":"89","author":"Harper","year":"1992","journal-title":"Human Genetics"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0470","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1073\/pnas.0501507102","article-title":"RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model","volume":"102","author":"Harper","year":"2005","journal-title":"Proceedings of the National Academy of Sciences United States of America"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0475","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s11064-007-9463-1","article-title":"Glutamate uptake is reduced in prefrontal cortex in Huntington's disease","volume":"33","author":"Hassel","year":"2008","journal-title":"Neurochemical Research"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0480","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1089\/ars.2009.2466","article-title":"Protein disulfide isomerase: a critical evaluation of its function in disulfide bond formation","volume":"11","author":"Hatahet","year":"2009","journal-title":"Antioxidants & Redox Signaling"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0485","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ajmg.1320110203","article-title":"Genetic aspects of Huntington's chorea: results of a national survey","volume":"11","author":"Hayden","year":"1982","journal-title":"American Journal of Medical Genetics"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0490","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrd2784","article-title":"Tetrabenazine","volume":"8","author":"Hayden","year":"2009","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0495","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00002093-200110000-00002","article-title":"Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050","volume":"15","author":"Hebert","year":"2001","journal-title":"Alzheimer Disease & Associated Disorders"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0500","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/ajmg.a.32901","article-title":"Estimating the probability of de novo HD cases from transmissions of expanded penetrant CAG alleles in the Huntington disease gene from male carriers of high normal alleles (27-35 CAG)","volume":"149A","author":"Hendricks","year":"2009","journal-title":"American Journal of Medical Genetics A"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0505","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1523\/JNEUROSCI.5599-08.2009","article-title":"In vivo evidence for NMDA receptor-mediated excitotoxicity in a murine genetic model of Huntington disease","volume":"29","author":"Heng","year":"2009","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0510","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/01.wnl.0000194318.74946.b6","article-title":"Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2\u2019Dg","volume":"66","author":"Hersch","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0515","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0278-5846(03)00021-6","article-title":"Apoptosis in Huntington's disease","volume":"27","author":"Hickey","year":"2003","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0520","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nchembio.467","article-title":"Inhibitors of protein disulfide isomerase suppress apoptosis induced by misfolded proteins","volume":"6","author":"Hoffstrom","year":"2010","journal-title":"Nature Chemical Biology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0525","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.nbd.2010.05.027","article-title":"Palmitoylation and function of glial glutamate transporter-1 is reduced in the YAC128 mouse model of Huntington disease","volume":"40","author":"Huang","year":"2010","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0530","first-page":"317","article-title":"On Chorea","volume":"26","author":"Huntington","year":"1872","journal-title":"The Medical and Surgical Reporter: A Weekly Journal"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0535","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1176\/appi.neuropsych.15.1.109","article-title":"On chorea. George Huntington, M.D","volume":"15","author":"Huntington","year":"2003","journal-title":"Journal of Neuropsychiatry & Clinical Neurosciences"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0540","doi-asserted-by":"crossref","unstructured":"Huntington Study Group Pre2CARE Investigators, 2010. Safety and tolerability of high-dosage coenzyme Q10 in Huntington's disease and healthy subjects. Movement Disorders 25, 1924\u20131928.","DOI":"10.1002\/mds.22408"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0545","doi-asserted-by":"crossref","first-page":"14294","DOI":"10.1074\/jbc.M312645200","article-title":"HIP1 and HIP1r stabilize receptor tyrosine kinases and bind 3-phosphoinositides via epsin N-terminal homology domains","volume":"279","author":"Hyun","year":"2004","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0550","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1042\/BJ20071619","article-title":"Huntington's disease: from pathology and genetics to potential therapies","volume":"412","author":"Imarisio","year":"2008","journal-title":"Biochemical Journal"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0555","unstructured":"Isis Pharmaceuticals, Inc., 2011. Press Release. Isis and CHDI Foundation Renew Drug Development Collaboration for Huntington's Disease. Retrieved February 15, 2012 from http:\/\/ir.isispharm.com\/phoenix.zhtml?c=222170&p=irol-newsArticle&ID=1595491&highlight=."},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0560","doi-asserted-by":"crossref","first-page":"13135","DOI":"10.1073\/pnas.0505801102","article-title":"Increased susceptibility of cytoplasmic over nuclear polyglutamine aggregates to autophagic degradation","volume":"102","author":"Iwata","year":"2005","journal-title":"Proceedings of the National Academy of Sciences United States of America"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0565","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S1474-4422(09)70183-8","article-title":"Treatment of hyperkinetic movement disorders","volume":"8","author":"Jankovic","year":"2009","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0570","series-title":"High Throughput Screening: Methods and Protocols","year":"2002"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1385","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.nbd.2012.01.016","article-title":"Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease","volume":"46","author":"Jia","year":"2012","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0580","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.nbd.2010.09.003","article-title":"Lentiviral delivery of meteorin protects striatal neurons against excitotoxicity and reverses motor deficits in the quinolinic acid rat model","volume":"41","author":"Jorgensen","year":"2011","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0585","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1001\/archneur.58.2.311","article-title":"Sydenham chorea","volume":"58","author":"Jummani","year":"2001","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0590","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/ng0597-44","article-title":"HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain","volume":"16","author":"Kalchman","year":"1997","journal-title":"Nature Genetics"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0595","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000110380","article-title":"Prevalence of chorea, dystonia and athetosis in Assiut, Egypt: a clinical and epidemiological study","volume":"13","author":"Kandil","year":"1994","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0600","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/bjc.1972.33","article-title":"Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics","volume":"26","author":"Kerr","year":"1972","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0605","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1385\/NMM:1:3:183","article-title":"Cytochrome C and caspase-9 expression in Huntington's disease","volume":"1","author":"Kiechle","year":"2002","journal-title":"Neuromolecular Medicine"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0610","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1093\/hmg\/ddq306","article-title":"Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease","volume":"19","author":"Kim","year":"2010","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0615","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.str.2009.08.002","article-title":"Secondary structure of Huntingtin amino-terminal region","volume":"17","author":"Kim","year":"2009","journal-title":"Structure"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0620","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archneur.58.2.273","article-title":"Progression of symptoms in the early and middle stages of Huntington disease","volume":"58","author":"Kirkwood","year":"2001","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0625","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1074\/mcp.M800007-MCP200","article-title":"Targets of caspase-6 activity in human neurons and Alzheimer disease","volume":"7","author":"Klaiman","year":"2008","journal-title":"Molecular & Cellular Proteomics"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0630","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ana.410410206","article-title":"Energy metabolism defects in Huntington's disease and effects of coenzyme Q10","volume":"41","author":"Koroshetz","year":"1997","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0635","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1212\/WNL.53.9.2169","article-title":"Relicts of dancing mania: the dancing procession of Echternach","volume":"53","author":"Krack","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0640","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199405193302001","article-title":"A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats","volume":"330","author":"Kremer","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0645","first-page":"343","article-title":"Sex-dependent mechanisms for expansions and contractions of the CAG repeat on affected Huntington disease chromosomes","volume":"57","author":"Kremer","year":"1995","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0650","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1021\/ci050352v","article-title":"Assessing the scaffold diversity of screening libraries","volume":"46","author":"Krier","year":"2006","journal-title":"Journal of Chemical Information and Modeling"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0655","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/cdd.2008.150","article-title":"Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009","volume":"16","author":"Kroemer","year":"2009","journal-title":"Cell Death & Differentiation"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0660","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.410120504","article-title":"Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan","volume":"12","author":"Kuhl","year":"1982","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0665","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/370223a0","article-title":"Nuclear protein CBP is a coactivator for the transcription factor CREB","volume":"370","author":"Kwok","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0670","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1126\/science.1115035","article-title":"Caspases 3 and 7: key mediators of mitochondrial events of apoptosis","volume":"311","author":"Lakhani","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0675","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1074\/mcp.M800132-MCP200","article-title":"Targeted peptidecentric proteomics reveals caspase-7 as a substrate of the caspase-1 inflammasomes","volume":"7","author":"Lamkanfi","year":"2008","journal-title":"Molecular & Cellular Proteomics"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0680","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1021\/ci2001428","article-title":"Scaffold diversity of exemplified medicinal chemistry space","volume":"51","author":"Langdon","year":"2011","journal-title":"Journal of Chemical Information and Modeling"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0685","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.cbpa.2011.05.008","article-title":"Molecular complexity and fragment-based drug discovery: ten years on","volume":"15","author":"Leach","year":"2011","journal-title":"Current Opinion in Chemical Biology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0690","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1086\/318207","article-title":"Wild-type huntingtin reduces the cellular toxicity of mutant huntingtin in vivo","volume":"68","author":"Leavitt","year":"2001","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0695","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1471-4159.2005.03605.x","article-title":"Wild-type huntingtin protects neurons from excitotoxicity","volume":"96","author":"Leavitt","year":"2006","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0700","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1242\/jcs.00928","article-title":"ENTH\/ANTH proteins and clathrin-mediated membrane budding","volume":"117","author":"Legendre-Guillemin","year":"2004","journal-title":"Journal of Cell Science"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0705","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1074\/jbc.M408430200","article-title":"Huntingtin interacting protein 1 (HIP1) regulates clathrin assembly through direct binding to the regulatory region of the clathrin light chain","volume":"280","author":"Legendre-Guillemin","year":"2005","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0710","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/jnen\/61.8.673","article-title":"Strain-dependent neurodevelopmental abnormalities in caspase-3-deficient mice","volume":"61","author":"Leonard","year":"2002","journal-title":"Journal of Neuropathology & Experimental Neurology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0715","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.nbd.2011.01.022","article-title":"AFQ056, a new mGluR5 antagonist for treatment of fragile X syndrome","volume":"42","author":"Levenga","year":"2011","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0720","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.chembiol.2010.08.014","article-title":"Identification and evaluation of small molecule pan-caspase inhibitors in Huntington's disease models","volume":"17","author":"Leyva","year":"2010","journal-title":"Chemistry & Biology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0725","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1128\/MCB.22.5.1277-1287.2002","article-title":"Interaction of Huntington disease protein with transcriptional activator Sp1","volume":"22","author":"Li","year":"2002","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0730","doi-asserted-by":"crossref","first-page":"15916","DOI":"10.1074\/jbc.M511007200","article-title":"Expression and characterization of full-length human huntingtin, an elongated HEAT repeat protein","volume":"281","author":"Li","year":"2006","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0735","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1006\/nbdi.2001.0430","article-title":"Impaired glutamate uptake in the R6 Huntington's disease transgenic mice","volume":"8","author":"Lievens","year":"2001","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0740","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/hmg\/2.10.1541","article-title":"Differential 3\u2032 polyadenylation of the Huntington disease gene results in two mRNA species with variable tissue expression","volume":"2","author":"Lin","year":"1993","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0745","unstructured":"Link Medicine, 2012. Our Approach. Retrieved February 7, 2012 from http:\/\/www.linkmedicine.com\/science\/approach.asp."},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0750","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1021\/jo8001276","article-title":"Structural diversity of organic chemistry. A scaffold analysis of the CAS Registry","volume":"73","author":"Lipkus","year":"2008","journal-title":"Journal of Organic Chemistry"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0755","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1073\/pnas.0806474106","article-title":"Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease","volume":"106","author":"Liu","year":"2009","journal-title":"Proceedings of the National Academy of Sciences United States of America"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0760","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0074-7742(09)89001-6","article-title":"Molecular profiling of striatonigral and striatopallidal medium spiny neurons past, present, and future","volume":"89","author":"Lobo","year":"2009","journal-title":"International Review of Neurobiology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0765","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/1531-8249(200007)48:1<72::AID-ANA11>3.0.CO;2-I","article-title":"Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy","volume":"48","author":"Lodi","year":"2000","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0770","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1212\/01.WNL.0000068165.07883.64","article-title":"IV amantadine improves chorea in Huntington's disease: an acute randomized, controlled study","volume":"60","author":"Lucetti","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0775","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/WNF.0b013e3181ebb285","article-title":"Efficacy and safety of the dopaminergic stabilizer Pridopidine (ACR16) in patients with Huntington's disease","volume":"33","author":"Lundin","year":"2010","journal-title":"Clinical Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0780","doi-asserted-by":"crossref","first-page":"7927","DOI":"10.1073\/pnas.1002924107","article-title":"SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis","volume":"107","author":"Luthi-Carter","year":"2010","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0785","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bbrc.2006.02.141","article-title":"rAAV-mediated shRNA ameliorated neuropathology in Huntington disease model mouse","volume":"343","author":"Machida","year":"2006","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0790","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0140-6736(90)92242-A","article-title":"Mitochondrial function and parental sex effect in Huntington's disease","volume":"336","author":"Mann","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0795","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1212\/WNL.42.1.223","article-title":"Cortical glucose metabolism in Huntington's disease","volume":"42","author":"Martin","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0800","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nn.2528","article-title":"Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease","volume":"13","author":"Martinez-Vicente","year":"2010","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0805","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM198702123160701","article-title":"Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease","volume":"316","author":"Mazziotta","year":"1987","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0810","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrm3151","article-title":"Molecular mechanism and physiological functions of clathrin-mediated endocytosis","volume":"12","author":"McMahon","year":"2011","journal-title":"Nature Reviews Molecular and Cellular Biology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0815","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1139\/o01-076","article-title":"CBP, a transcriptional coactivator and acetyltransferase","volume":"79","author":"McManus","year":"2001","journal-title":"Biochemistry and Cell Biology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0820","doi-asserted-by":"crossref","first-page":"39271","DOI":"10.1074\/jbc.C100401200","article-title":"HIP1 functions in clathrin-mediated endocytosis through binding to clathrin and adaptor protein 2","volume":"276","author":"Metzler","year":"2001","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0825","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1093\/emboj\/cdg334","article-title":"Disruption of the endocytic protein HIP1 results in neurological deficits and decreased AMPA receptor trafficking","volume":"22","author":"Metzler","year":"2003","journal-title":"EMBO Journal"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0830","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1523\/JNEUROSCI.5175-06.2007","article-title":"NMDA receptor function and NMDA receptor-dependent phosphorylation of huntingtin is altered by the endocytic protein HIP1","volume":"27","author":"Metzler","year":"2007","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0835","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.neuroscience.2008.02.004","article-title":"Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6\/2 mouse","volume":"153","author":"Miller","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0840","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1083\/jcb.200503106","article-title":"Huntingtin interacting protein 1 modulates the transcriptional activity of nuclear hormone receptors","volume":"170","author":"Mills","year":"2005","journal-title":"Journal of Cell Biology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0845","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2010.01.008","article-title":"Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice","volume":"65","author":"Milnerwood","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0850","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0301-0082(96)00042-1","article-title":"The basal ganglia: focused selection and inhibition of competing motor programs","volume":"50","author":"Mink","year":"1996","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0855","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nn.2346","article-title":"Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin","volume":"12","author":"Morfini","year":"2009","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0860","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1021\/jm0611962","article-title":"Application of fragment screening by X-ray crystallography to beta-secretase","volume":"50","author":"Murray","year":"2007","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0865","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nchem.217","article-title":"The rise of fragment-based drug discovery","volume":"1","author":"Murray","year":"2009","journal-title":"Nature Chemistry"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0870","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0092-8674(00)81266-0","article-title":"FLICE, a novel FADD-homologous ICE\/CED-3-like protease, is recruited to the CD95 (Fas\/APO-1) death-inducing signaling complex","volume":"85","author":"Muzio","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0875","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.molcel.2010.07.002","article-title":"Transnitrosylation of XIAP regulates caspase-dependent neuronal cell death","volume":"39","author":"Nakamura","year":"2010","journal-title":"Molecular Cell"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0880","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000109899","article-title":"Epidemiological and genetic studies of Huntington's Disease in the San-in Area of Japan","volume":"15","author":"Nakashima","year":"1996","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0885","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0092-8674(95)90542-1","article-title":"Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes","volume":"81","author":"Nasir","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0890","doi-asserted-by":"crossref","first-page":"e1000291","DOI":"10.1371\/journal.pbio.1000291","article-title":"Modulation of heat shock transcription factor 1 as a therapeutic target for small molecule intervention in neurodegenerative disease","volume":"8","author":"Neef","year":"2010","journal-title":"PLoS Biology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0895","unstructured":"Neuralstem, Inc., 2011. Neuralstem Cell Therapy: Repairing and Replacing Damaged Cells Retrieved February 15, 2012 from http:\/\/www.neuralstem.com\/cell-therapy."},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0900","unstructured":"Neurologix, Inc., 2011. Product Pipeline. Huntington's Disease. Retrieved February 5, 2012 from http:\/\/www.neurologix.net\/products\/huntingtons.html."},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0905","doi-asserted-by":"crossref","first-page":"11840","DOI":"10.1073\/pnas.0502177102","article-title":"Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model","volume":"102","author":"Nguyen","year":"2005","journal-title":"Proceedings of the National Academy of Sciences United States of America"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0910","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.jmb.2007.11.036","article-title":"Crystal structure at 2.8 A of Huntingtin-interacting protein 1 (HIP1) coiled-coil domain reveals a charged surface suitable for HIP1 protein interactor (HIPPI)","volume":"375","author":"Niu","year":"2008","journal-title":"Journal of Molecular Biology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0915","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jnen\/64.2.113","article-title":"Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study","volume":"64","author":"Nixon","year":"2005","journal-title":"Journal of Neuropathology & Experimental Neurology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0920","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.tins.2006.07.003","article-title":"Autophagy in neurodegenerative disease: friend, foe or turncoat?","volume":"29","author":"Nixon","year":"2006","journal-title":"Trends in Neuroscience"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0925","unstructured":"NsGene A\/S, 2012. NsG33-Meteorin. Retrieved February 15, 2012 from http:\/\/nsgene.dk\/NsGene-413.aspx."},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0930","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","article-title":"Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity","volume":"291","author":"Nucifora","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0935","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1107\/S1744309105010109","article-title":"Structural analysis of caspase-1 inhibitors derived from Tethering","volume":"61","author":"O\u2019Brien","year":"2005","journal-title":"Acta Crystallographica Section F Structural Biology and Crystallization Communications"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0940","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/nm.2056","article-title":"Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin","volume":"15","author":"Okamoto","year":"2009","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0945","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0006-8993(98)01312-2","article-title":"Neuronal degeneration in the basal ganglia and loss of pallido-subthalamic synapses in mice with targeted disruption of the Huntington's disease gene","volume":"818","author":"O\u2019Kusky","year":"1999","journal-title":"Brain Research"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0950","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/20446","article-title":"Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease","volume":"399","author":"Ona","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0955","unstructured":"Oryzon, 2012. Press Release 2012. Oryzon nominates bispecific LSD1\/MAOB inhibitor as drug candidate to enter preclinical development in Huntington's Disease. Retrieved February 15, 2012 from http:\/\/www.oryzon.com\/files\/PRESS_RELEASE_2002-2012.pdf."},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0960","doi-asserted-by":"crossref","unstructured":"Osler, S.W., 1894. Historical note. Etiology, in: On Chorea and Choreiform Affections. H.K. Lewis, London, pp. 3\u201319.","DOI":"10.1097\/00000441-189503000-00011"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0965","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.cell.2007.10.040","article-title":"A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion","volume":"131","author":"Overholtzer","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0970","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines","volume":"5","author":"Panov","year":"2002","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0975","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1177\/014107689008300814","article-title":"Saint Vitus\u2019 dance: vital misconceptions by Sydenham and Bruegel","volume":"83","author":"Park","year":"1990","journal-title":"Journal of Royal Society of Medicine"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0980","doi-asserted-by":"crossref","first-page":"11056","DOI":"10.1523\/JNEUROSCI.1941-07.2007","article-title":"Huntingtin-interacting protein 1 influences worm and mouse presynaptic function and protects Caenorhabditis elegans neurons against mutant polyglutamine toxicity","volume":"27","author":"Parker","year":"2007","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0985","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0306-4522(00)00074-9","article-title":"Neurturin protects striatal projection neurons but not interneurons in a rat model of Huntington's disease","volume":"98","author":"Perez-Navarro","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0990","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/mds.21971","article-title":"The current clinical management of Huntington's disease","volume":"23","author":"Phillips","year":"2008","journal-title":"Movement Disorders"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib0995","unstructured":"Plexxikon, Inc., 2011. Oncology. Melanoma & BRAF Mutant Cancer Program. Retrieved August 30, 2011 from www.plexxikon.com\/file.cfm\/13\/docs\/Plexxikon_Melanoma_v15%203%20final_080211.pdf."},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1000","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1073\/pnas.0609833104","article-title":"Selective defect of in vivo glycolysis in early Huntington's disease striatum","volume":"104","author":"Powers","year":"2007","journal-title":"Proceedings of the National Academy of Sciences United States of America"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1005","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/1531-8249(200001)47:1<64::AID-ANA11>3.0.CO;2-S","article-title":"Higher sedentary energy expenditure in patients with Huntington's disease","volume":"47","author":"Pratley","year":"2000","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1010","unstructured":"Prosensa, 2012. HD-Huntington Disease. Retrieved February 16, 2012 from http:\/\/prosensa.eu\/patients-and-family\/huntington-disease."},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1523\/JNEUROSCI.1409-03.2004","article-title":"Huntingtin bodies sequester vesicle-associated proteins by a polyproline-dependent interaction","volume":"24","author":"Qin","year":"2004","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1020","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1136\/jmg.2006.045120","article-title":"Reduced penetrance alleles for Huntington's disease: a multi-centre direct observational study","volume":"44","author":"Quarrell","year":"2007","journal-title":"Journal of Medical Genetics"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1025","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.nbd.2007.01.003","article-title":"Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's disease","volume":"26","author":"Ramaswamy","year":"2007","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1030","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.nbd.2008.12.005","article-title":"Intrastriatal CERE-120 (AAV-Neurturin) protects striatal and cortical neurons and delays motor deficits in a transgenic mouse model of Huntington's disease","volume":"34","author":"Ramaswamy","year":"2009","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1035","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/hmg\/11.9.1107","article-title":"Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy","volume":"11","author":"Ravikumar","year":"2002","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1040","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng1362","article-title":"Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease","volume":"36","author":"Ravikumar","year":"2004","journal-title":"Nature Genetics"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1045","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1566-2772(03)00054-9","article-title":"Excitotoxicity in Huntington disease","volume":"3","author":"Raymond","year":"2003","journal-title":"Clinical Neuroscience Research"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1050","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nrd1467","article-title":"Fragment-based lead discovery","volume":"3","author":"Rees","year":"2004","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1055","unstructured":"ReNeuron, 2011. ReNeuron presents further pre-clinical stem cell data at US conference. 27\/10\/04. Retrieved February 5, 2012 from http:\/\/www.reneuron.co.uk\/monthly-archive\/91-reneuron-presents-further-pre-clinical-stem-cell-data-at-us-conference-271004."},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1060","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1523\/JNEUROSCI.20-10-03705.2000","article-title":"Wild-type huntingtin protects from apoptosis upstream of caspase-3","volume":"20","author":"Rigamonti","year":"2000","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1065","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1070","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nature03180","article-title":"Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression","volume":"433","author":"Rothstein","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1075","first-page":"16","article-title":"Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats","volume":"59","author":"Rubinsztein","year":"1996","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1080","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/emboj\/21.8.1967","article-title":"Caspase-6 gene disruption reveals a requirement for lamin A cleavage in apoptotic chromatin condensation","volume":"21","author":"Ruchaud","year":"2002","journal-title":"EMBO Journal"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1085","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.physbeh.2011.04.001","article-title":"A ketogenic diet delays weight loss and does not impair working memory or motor function in the R6\/2 1J mouse model of Huntington's disease","volume":"103","author":"Ruskin","year":"2011","journal-title":"Physiology & Behavior"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1090","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/mds.20373","article-title":"Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease","volume":"20","author":"Saft","year":"2005","journal-title":"Movement Disorders"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1095","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0896-6273(00)80716-3","article-title":"Caspase-8 is required for cell death induced by expanded polyglutamine repeats","volume":"22","author":"Sanchez","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1100","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1423-0127-17-62","article-title":"Ceftriaxone-induced up-regulation of cortical and striatal GLT1 in the R6\/2 model of Huntington's disease","volume":"17","author":"Sari","year":"2010","journal-title":"Journal of Biomedical Science"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","article-title":"Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions","volume":"95","author":"Saudou","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1110","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainres.2003.09.049","article-title":"Oral uridine pro-drug PN401 decreases neurodegeneration, behavioral impairment, weight loss and mortality in the 3-nitropropionic acid mitochondrial toxin model of Huntington's disease","volume":"994","author":"Saydoff","year":"2003","journal-title":"Brain Research"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1115","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.nbd.2006.08.011","article-title":"Oral uridine pro-drug PN401 is neuroprotective in the R6\/2 and N171-82Q mouse models of Huntington's disease","volume":"24","author":"Saydoff","year":"2006","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1120","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1152\/physrev.00025.2007","article-title":"Transcriptional paradigms in mammalian mitochondrial biogenesis and function","volume":"88","author":"Scarpulla","year":"2008","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1125","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1474-4422(04)00737-9","article-title":"Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis","volume":"3","author":"Schols","year":"2004","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1130","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2174\/1568026054637700","article-title":"Library design for fragment based screening","volume":"5","author":"Schuffenhauer","year":"2005","journal-title":"Current Topics in Medicinal Chemistry"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1135","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1136\/jmg.18.3.200","article-title":"Huntington's disease in Tanzania","volume":"18","author":"Scrimgeour","year":"1981","journal-title":"Journal of Medical Genetics"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1140","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1126\/science.274.5292.1531","article-title":"Discovering high-affinity ligands for proteins: SAR by NMR","volume":"274","author":"Shuker","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1145","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1073\/pnas.0811228106","article-title":"Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice","volume":"106","author":"Simmons","year":"2009","journal-title":"Proceedings of the National Academy of Sciences United States of America"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1150","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.nbd.2010.10.015","article-title":"Brief ampakine treatments slow the progression of Huntington's disease phenotypes in R6\/2 mice","volume":"41","author":"Simmons","year":"2011","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1155","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1093\/hmg\/11.23.2815","article-title":"HIP14, a novel ankyrin domain-containing protein, links huntingtin to intracellular trafficking and endocytosis","volume":"11","author":"Singaraja","year":"2002","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1160","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1586\/14737175.8.12.1829","article-title":"What's in the pipeline for the treatment of Parkinson's disease?","volume":"8","author":"Sommer","year":"2008","journal-title":"Expert Review of Neurotherapeutics"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1165","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nm.2313","article-title":"Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity","volume":"17","author":"Song","year":"2011","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1170","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/jmg.29.12.911","article-title":"Causes of death in patients with Huntington's disease and in unaffected first degree relatives","volume":"29","author":"Sorensen","year":"1992","journal-title":"Journal of Medical Genetics"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1175","doi-asserted-by":"crossref","first-page":"14376","DOI":"10.1073\/pnas.97.26.14376","article-title":"An alternative, nonapoptotic form of programmed cell death","volume":"97","author":"Sperandio","year":"2000","journal-title":"Proceedings of the National Academy of Sciences United States of America"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1180","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.expneurol.2011.11.020","article-title":"Widespread suppression of huntingtin with convection-enhanced delivery of siRNA","volume":"233","author":"Stiles","year":"2011","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1185","doi-asserted-by":"crossref","first-page":"8395","DOI":"10.1073\/pnas.93.16.8395","article-title":"Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis","volume":"93","author":"Takahashi","year":"1996","journal-title":"Proceedings of the National Academy of Sciences United States of America"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1190","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2202-3-15","article-title":"The predominantly HEAT-like motif structure of huntingtin and its association and coincident nuclear entry with dorsal, an NF-kB\/Rel\/dorsal family transcription factor","volume":"3","author":"Takano","year":"2002","journal-title":"BMC Neuroscience"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1195","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1073\/pnas.0409402102","article-title":"Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease","volume":"102","author":"Tang","year":"2005","journal-title":"Proceedings of the National Academy of Sciences United States of America"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1200","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1074\/jbc.M111.308668","article-title":"Different 8-Hydroxyquinolines Protect Models of TDP-43 Protein, alpha-Synuclein, and Polyglutamine Proteotoxicity through Distinct Mechanisms","volume":"287","author":"Tardiff","year":"2012","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1205","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/hmg\/2.10.1535","article-title":"Molecular analysis of juvenile Huntington disease: the major influence on (CAG) n repeat length is the sex of the affected parent","volume":"2","author":"Telenius","year":"1993","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1210","doi-asserted-by":"crossref","unstructured":"The Huntington's Disease Collaborative Research Group, 1993. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971\u2013983.","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1215","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/356768a0","article-title":"A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes","volume":"356","author":"Thornberry","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1220","doi-asserted-by":"crossref","first-page":"17907","DOI":"10.1074\/jbc.272.29.17907","article-title":"A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis","volume":"272","author":"Thornberry","year":"1997","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1225","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1148\/radiol.2351041768","article-title":"Prevalence and costs of chronic disease in a health care system structured for treatment of acute illness","volume":"235","author":"Thrall","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1230","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/sj.bjp.0705662","article-title":"Neuroprotective effects of M826, a reversible caspase-3 inhibitor, in the rat malonate model of Huntington's disease","volume":"141","author":"Toulmond","year":"2004","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1235","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1073\/pnas.0711741105","article-title":"Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity","volume":"105","author":"Tsai","year":"2008","journal-title":"Proceedings of the National Academy of Sciences United States of America"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1240","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nrm2970","article-title":"Molecular mechanisms of necroptosis: an ordered cellular explosion","volume":"11","author":"Vandenabeele","year":"2010","journal-title":"Nature Reviews Molecular and Cellular Biology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1245","unstructured":"Vertex Pharmaceuticals, Inc., 2010. VX-765 (Epilepsy). Retrieved June 3, 2011 from www.vrtx.com\/current-projects\/drug-candidates\/pipeline.html."},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1250","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1440-1681.2009.05277.x","article-title":"Cross-talk between L-type Ca2+ channels and mitochondria","volume":"37","author":"Viola","year":"2010","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1255","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"Journal of Neuropathology & Experimental Neurology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1260","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/hmg\/10.17.1807","article-title":"The huntingtin interacting protein HIP1 is a clathrin and alpha-adaptin-binding protein involved in receptor-mediated endocytosis","volume":"10","author":"Waelter","year":"2001","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1265","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington's disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1270","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0140-6736(09)60386-X","article-title":"A forgotten plague: making sense of dancing mania","volume":"373","author":"Waller","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1275","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/hmg\/ddn404","article-title":"Effects of overexpression of huntingtin proteins on mitochondrial integrity","volume":"18","author":"Wang","year":"2009","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1280","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1750-1326-5-18","article-title":"Tetrabenazine is neuroprotective in Huntington's disease mice","volume":"5","author":"Wang","year":"2010","journal-title":"Molecular Neurodegeneration"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1285","doi-asserted-by":"crossref","first-page":"10483","DOI":"10.1073\/pnas.1832501100","article-title":"Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease","volume":"100","author":"Wang","year":"2003","journal-title":"Proceedings of the National Academy of Sciences United States of America"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1290","doi-asserted-by":"crossref","first-page":"11645","DOI":"10.1523\/JNEUROSCI.4181-05.2005","article-title":"Dysregulation of receptor interacting protein-2 and caspase recruitment domain only protein mediates aberrant caspase-1 activation in Huntington's disease","volume":"25","author":"Wang","year":"2005","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1295","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/hmg\/6.3.487","article-title":"HIP-I: a huntingtin interacting protein isolated by the yeast two-hybrid system","volume":"6","author":"Wanker","year":"1997","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1300","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ajhg.2009.02.003","article-title":"CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup","volume":"84","author":"Warby","year":"2009","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1305","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/ejhg.2010.229","article-title":"HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia","volume":"19","author":"Warby","year":"2011","journal-title":"European Journal of Human Genetics"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1310","doi-asserted-by":"crossref","first-page":"pe25","DOI":"10.1126\/stke.121pe25","article-title":"ETosis: a novel cell death pathway","volume":"1","author":"Wartha","year":"2008","journal-title":"Science Signaling"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1315","doi-asserted-by":"crossref","first-page":"19831","DOI":"10.1074\/jbc.M001475200","article-title":"Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells","volume":"275","author":"Wellington","year":"2000","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1320","doi-asserted-by":"crossref","first-page":"32870","DOI":"10.1074\/jbc.M802863200","article-title":"Actin binding by Hip1 (huntingtin-interacting protein 1) and Hip1R (Hip1-related protein) is regulated by clathrin light chain","volume":"283","author":"Wilbur","year":"2008","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1325","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/pn.2007.134585","article-title":"The differential diagnosis of chorea","volume":"7","author":"Wild","year":"2007","journal-title":"Practical Neurology"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1330","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bbapap.2004.02.017","article-title":"Protein disulfide isomerase","volume":"1699","author":"Wilkinson","year":"2004","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1335","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0014-2999(00)00024-8","article-title":"Systemic administration of 4-chlorokynurenine prevents quinolinate neurotoxicity in the rat hippocampus","volume":"390","author":"Wu","year":"2000","journal-title":"European Journal of Pharmacology"},{"issue":"Suppl 2","key":"10.1016\/j.pneurobio.2012.08.004_bib1340","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/sj.cdd.4401765","article-title":"Autophagy: molecular machinery for self-eating","volume":"12","author":"Yorimitsu","year":"2005","journal-title":"Cell Death & Differentiation"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1345","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.brainres.2008.08.053","article-title":"Motoneuronotrophic factor analog GM6 reduces infarct volume and behavioral deficits following transient ischemia in the mouse","volume":"1238","author":"Yu","year":"2008","journal-title":"Brain Research"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1350","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ng1095-155","article-title":"Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue","volume":"11","author":"Zeitlin","year":"1995","journal-title":"Nature Genetics"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1355","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.cell.2005.10.030","article-title":"In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets","volume":"123","author":"Zhai","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1360","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.1038\/sj.emboj.7601445","article-title":"Huntingtin inhibits caspase-3 activation","volume":"25","author":"Zhang","year":"2006","journal-title":"EMBO Journal"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1365","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1471-4159.2005.03340.x","article-title":"Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition","volume":"95","author":"Zheng","year":"2005","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1370","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng1219","article-title":"Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes","volume":"35","author":"Zuccato","year":"2003","journal-title":"Nature Genetics"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1375","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00041.2009","article-title":"Molecular mechanisms and potential therapeutical targets in Huntington's disease","volume":"90","author":"Zuccato","year":"2010","journal-title":"Physiological Review"},{"key":"10.1016\/j.pneurobio.2012.08.004_bib1380","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1093\/hmg\/2.12.2063","article-title":"Mitotic stability and meiotic variability of the (CAG)n repeat in the Huntington disease gene","volume":"2","author":"Zuhlke","year":"1993","journal-title":"Human Molecular Genetics"}],"container-title":["Progress in Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008212001360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008212001360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T19:10:10Z","timestamp":1643310610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301008212001360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":276,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0301008212001360"],"URL":"https:\/\/doi.org\/10.1016\/j.pneurobio.2012.08.004","relation":{},"ISSN":["0301-0082"],"issn-type":[{"value":"0301-0082","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}